Tech Company Financing Transactions

Prometheus Biosciences Funding Round

On 11/10/2020, Prometheus Biosciences announced $130 million in funding from Eventide Asset Management, RTW Investments and AGI Partners.

Transaction Overview

Announced On
Transaction Type
Venture Equity
Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Mailing Address
9410 Carroll Park Dr.
San Diego, CA 92121
Email Address
Prometheus Biosciences is a forward-thinking biopharmaceutical company that is dedicated to disrupting the treatment paradigm of GI diseases. We will do this by discovering and developing a broad portfolio of novel precision therapeutics and diagnostics that will meaningfully impact patient care.
Prometheus Biosciences LinkedIn Company Profile
Social Media
Prometheus Biosciences Company Twitter Account
Company News
Prometheus Biosciences News
Prometheus Biosciences on Facebook
Prometheus Biosciences on YouTube

Management Team

Email & Social
Chief Executive Officer
Mark McKenna
  Mark McKenna LinkedIn Profile  Mark McKenna Twitter Account  Mark McKenna News  Mark McKenna on Facebook
Chief Financial Officer
Keith Marshall
  Keith Marshall LinkedIn Profile  Keith Marshall Twitter Account  Keith Marshall News  Keith Marshall on Facebook
Chief Medical Officer
Allison Luo
  Allison Luo LinkedIn Profile  Allison Luo Twitter Account  Allison Luo News  Allison Luo on Facebook
Chief Operating Officer
Lauren Otsuki
  Lauren Otsuki LinkedIn Profile  Lauren Otsuki Twitter Account  Lauren Otsuki News  Lauren Otsuki on Facebook
Chief Scientific Officer
Laurens Kruidenier
  Laurens Kruidenier LinkedIn Profile  Laurens Kruidenier Twitter Account  Laurens Kruidenier News  Laurens Kruidenier on Facebook
Chief Technical Officer
Olivier Laurent
  Olivier Laurent LinkedIn Profile  Olivier Laurent Twitter Account  Olivier Laurent News  Olivier Laurent on Facebook
Vice President
Brian Littlefield
  Brian Littlefield LinkedIn Profile  Brian Littlefield Twitter Account  Brian Littlefield News  Brian Littlefield on Facebook
VP - Bus. Development
Robert Armstrong
  Robert Armstrong LinkedIn Profile  Robert Armstrong Twitter Account  Robert Armstrong News  Robert Armstrong on Facebook
VP - Bus. Development
Thierry Dervieux
  Thierry Dervieux LinkedIn Profile  Thierry Dervieux Twitter Account  Thierry Dervieux News  Thierry Dervieux on Facebook
VP - Bus. Development
Michael Walther
  Michael Walther LinkedIn Profile  Michael Walther Twitter Account  Michael Walther News  Michael Walther on Facebook
VP - Finance
Vika Brough
  Vika Brough LinkedIn Profile  Vika Brough Twitter Account  Vika Brough News  Vika Brough on Facebook



Browse more venture capital transactions:

Prev: 11/10/2020: Stargazer Pharmaceuticals venture capital transaction
Next: 11/10/2020: Ambrx venture capital transaction


Share this article


Where The Data Comes From

We do our best to document every notable VC transaction. VC investment data records reported here are sourced from publicly available VC deal announcements. The data is sourced from, an affiliated venture.


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities


Business Glossary